Pharma Focus Asia

LFB Biomanufacturing Expands its Biomedical Production Capacity in France, Europe

Introduction:

LFB Biomanufacturing is planning a capacity expansion of its industrial site in France, Europe.

Features: 

The expansion will not only boost production capabilities but also enhance the site's infrastructure with the addition of new development and analytical service laboratories, along with a raw material warehouse. 

These enhancements are crucial for supporting the complex processes involved in biomedicinal product development and production.

This project comes at a time when the demand for biomedicinal products is surging worldwide, highlighting the importance of robust and scalable production facilities. 

By expanding its capacity, LFB Biomanufacturing is positioning itself to better meet these growing needs, ensuring a steady supply of therapeutic proteins.

Moreover, this expansion will reinforce France's position as a leader in bioproduction within Europe and on the global stage. 

The project is also set to stimulate the local economy with the creation of approximately 50 new jobs by 2026, reflecting its commitment to both innovation and community growth.

Specifications:

Name    LFB Biomanufacturing
Type      Expansion
Year       2026

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference